EMERGEX VACCINES HOLDINGS LTD has a total of 12 patent applications. It increased the IP activity by 500.0%. Its first patent ever was published in 2012. It filed its patents most often in EPO (European Patent Office), United States and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are SCHWEIZ SERUM & IMPFINST, SERUM INSTITUTE OF INDIA PRIVATE LTD and INVENTPRISE LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | United States | 2 | |
#3 | Canada | 1 | |
#4 | China | 1 | |
#5 | Singapore | 1 | |
#6 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Climate change adaptation technologies | |
#5 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Philip Ramila | 12 |
#2 | Rademacher Thomas | 3 |
#3 | Rademacher Laurens | 2 |
#4 | Upton Christopher | 1 |
#5 | Huang Xiaofang | 1 |
#6 | Perrins Richard David | 1 |